​

Nephros (NEPH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NEPH Stock Rating

Nephros stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

NEPH Price Target Upside V Benchmarks

TypeNameUpside
StockNephros-
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks27.35%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.87$2.87$2.87
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 262----2
Mar, 2611---2
Feb, 2611---2
Jan, 2611---2
Dec, 2511---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 08, 2024BenchmarkBuyupgrade

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-0.41$-0.72$-0.15$0.01$0.11-
Avg Forecast$-0.42$-0.70$-0.12$-0.04$0.02$0.07
High Forecast$-0.41$-0.69$-0.10$-0.03$0.02$0.07
Low Forecast$-0.42$-0.70$-0.14$-0.05$0.02$0.07
Surprise %-2.38%2.86%25.00%-125.00%450.00%-

Revenue Forecast

$10M $11M $13M $15M $17M $19M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$10.22M$9.97M$14.24M$14.16M$18.79M-
Avg Forecast$10.47M$10.29M$14.80M$13.86M$15.13M$17.02M
High Forecast$10.59M$10.32M$14.81M$13.93M$15.13M$17.02M
Low Forecast$10.35M$10.27M$14.78M$13.79M$15.13M$17.02M
Surprise %-2.46%-3.07%-3.78%2.16%24.21%-

Net Income Forecast

$-8M $-6M $-4M $-2M $-300K $2M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-4.11M$-7.38M$-1.57M$74.00K$1.19M-
Avg Forecast$-4.32M$-5.05M$-1.57M$-415.44K$207.72K$727.02K
High Forecast$-3.45M$-4.04M$-1.26M$-311.58K$207.72K$727.02K
Low Forecast$-5.18M$-6.06M$-1.89M$-519.30K$207.72K$727.02K
Surprise %-4.83%46.07%--117.81%474.81%-

NEPH Forecast FAQ

Is Nephros stock a buy?

Nephros stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Nephros is a favorable investment for most analysts.

What is Nephros's price target?

Nephros's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $2.87.

How does Nephros stock forecast compare to its benchmarks?

Nephros's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical instruments & supplies stocks industry (27.35%).

What is the breakdown of analyst ratings for Nephros over the past three months?

  • April 2026: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Nephros’s EPS forecast?

Nephros's average annual EPS forecast for its fiscal year ending in December 2026 is $0.07, marking a -36.36% decrease from the reported $0.11 in 2025..

What is Nephros’s revenue forecast?

Nephros's average annual revenue forecast for its fiscal year ending in December 2026 is $17.02M, reflecting a -9.43% decrease from the reported $18.79M in 2025.

What is Nephros’s net income forecast?

Nephros's net income forecast for the fiscal year ending in December 2026 stands at $727.02K, representing a -39.11% decrease from the reported $1.19M in 2025.